Anti-ARHGEF12 monoclonal antibody
Pre-made anti-ARHGEF12 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to ARHGEF12/ARHGEF12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2353-Ab-1/ GM-Tg-hg-IP2353-Ab-2 | Anti-Human ARHGEF12 monoclonal antibody | Human |
GM-Tg-rg-IP2353-Ab-1/ GM-Tg-rg-IP2353-Ab-2 | Anti-Rat ARHGEF12 monoclonal antibody | Rat |
GM-Tg-mg-IP2353-Ab-1/ GM-Tg-mg-IP2353-Ab-2 | Anti-Mouse ARHGEF12 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2353-Ab-1/ GM-Tg-cynog-IP2353-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ARHGEF12 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2353-Ab-1/ GM-Tg-felg-IP2353-Ab-2 | Anti-Feline ARHGEF12 monoclonal antibody | Feline |
GM-Tg-cang-IP2353-Ab-1/ GM-Tg-cang-IP2353-Ab-2 | Anti-Canine ARHGEF12 monoclonal antibody | Canine |
GM-Tg-bovg-IP2353-Ab-1/ GM-Tg-bovg-IP2353-Ab-2 | Anti-Bovine ARHGEF12 monoclonal antibody | Bovine |
GM-Tg-equg-IP2353-Ab-1/ GM-Tg-equg-IP2353-Ab-2 | Anti-Equine ARHGEF12 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2353-Ab-1/ GM-Tg-hg-IP2353-Ab-2; GM-Tg-rg-IP2353-Ab-1/ GM-Tg-rg-IP2353-Ab-2; GM-Tg-mg-IP2353-Ab-1/ GM-Tg-mg-IP2353-Ab-2; GM-Tg-cynog-IP2353-Ab-1/ GM-Tg-cynog-IP2353-Ab-2; GM-Tg-felg-IP2353-Ab-1/ GM-Tg-felg-IP2353-Ab-2; GM-Tg-cang-IP2353-Ab-1/ GM-Tg-cang-IP2353-Ab-2; GM-Tg-bovg-IP2353-Ab-1/ GM-Tg-bovg-IP2353-Ab-2; GM-Tg-equg-IP2353-Ab-1/ GM-Tg-equg-IP2353-Ab-2 |
Products Name | Anti-ARHGEF12 monoclonal antibody |
Format | mab |
Target Name | ARHGEF12 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-ARHGEF12 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2353-Ag-1 | Recombinant multi-species ARHGC/ ARHGEF12/ LARG protein |
Target information
Target ID | GM-IP2353 |
Target Name | ARHGEF12 |
Gene ID | 23365,69632,367072,712096,479409,101085657,503575,100071503 |
Gene Symbol and Synonyms | 2310014B11Rik,ARHGEF12,LARG,mKIAA0382,PRO2792 |
Uniprot Accession | Q9NZN5 |
Uniprot Entry Name | ARHGC_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000196914 |
Target Classification | Tumor-associated antigen (TAA) |
The target: ARHGEF12, gene name: ARHGEF12, also named as LARG, PRO2792. Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli working through G protein-coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein has been observed to form a myeloid/lymphoid fusion partner in acute myeloid leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.